secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2026-09-30T13:05:42+00:00
Accession:  0001493152-26-045040
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Indaptus Therapeutics extends $24M private placement outside date to October 16, 2026
--------------------------------------------------------------------------------

- Indaptus Therapeutics and the purchasers signed Notices and Consents on September 29, 2026 extending the Stock Purchase Agreement outside date from September 29 to October 16, 2026.
- The September 8, 2026 Stock Purchase Agreement covers a private placement of common stock for aggregate gross proceeds of approximately $24.0 million before expenses.
- Closing may be deferred and coordinated across purchasers until Section 7 conditions are satisfied or waived, but no later than the Extended Outside Date.
- The funding deadline and related termination rights were extended to October 16, 2026, and the 60-day period under Section 3.1 now begins after the Extended Outside Date.
- The company may retain previously delivered Subscription Amounts pending closing without breaching the agreement; CEO Junyi Dai signed the filing on September 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226045040/0001493152-26-045040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226045040/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-045040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer